DUBLIN–(BUSINESS WIRE)–The “Hemoglobin Testing: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Hemoglobin Testing Market to Reach $3.2 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Hemoglobin Testing estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 5.6% over the period 2020-2027. Reagents & Consumables, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$2.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Equipment segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $599.9 Million, While China is Forecast to Grow at 8.5% CAGR
The Hemoglobin Testing market in the U.S. is estimated at US$599.9 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$683.3 Million by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.
Select Competitors (Total 44 Featured) –
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation
EKF Diagnostics Holdings PLC
F. Hoffmann-La Roche AG
Siemens Healthineers
Thermo Fisher Scientific, Inc.
What’s New for 2022?
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies – Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and a Research Platform
Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Hemoglobin Testing – Global Key Competitors Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
IV. COMPETITION
Companies Mentioned
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation
EKF Diagnostics Holdings PLC
F. Hoffmann-La Roche AG
Siemens Healthineers
Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/zdyjry
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
